TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $239,000 | -54.4% | 22,232 | -65.6% | 0.02% | -72.1% |
| Q2 2020 | $524,000 | +3393.3% | 64,711 | +338.0% | 0.06% | +6000.0% |
| Q4 2019 | $15,000 | +36.4% | 14,774 | -57.8% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | +83.3% | 34,991 | +79.0% | 0.00% | – |
| Q2 2019 | $6,000 | -68.4% | 19,548 | +77.2% | 0.00% | -100.0% |
| Q4 2018 | $19,000 | -86.8% | 11,029 | -44.6% | 0.00% | -87.5% |
| Q4 2017 | $144,000 | – | 19,898 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |